The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, represents a complex multi-step synthetic process. Preliminary routes focused on protein fragment coupling, utilizing https://albiejgwj881087.fare-blog.com/41110112/creation-and-research-uses-of-retatrutide